A world leader in pharmacology, toxicology, and pharmaceutics, Shenyang Pharmaceutical University (SPU) provides higher education to 8,093 undergraduate and 2,768 postgraduate students at its Shenyang and Benxi campuses in Liaoning Province, China.
At its two post-doctoral research stations, SPU focuses on using multi-disciplinary approaches and innovative technologies to create next-generation treatments. The university has broken new ground in the search for solutions to many health problems and led various clinical trial programs.